B7-H3 as a Novel CAR-T Therapeutic Target for Glioblastoma
2019 · Molecular Therapy — Oncolytics · 211 citations
https://doi.org/10.1016/j.omto.2019.07.002
Z
Zongliang Zhang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
84
Papers
1.9K
Citations
20
h-index
34
i10-index
Zongliang Zhang is an academic researcher from Qingdao University. The author has contributed to research in topics: CAR-T cell therapy research & Monoclonal and Polyclonal Antibodies Research & Virus-based gene therapy research. The author has an h-index of 20, co-authored 72 publications.
ORCID: 0000-0003-1859-0451Papers by this author
worksCXCL11-armed oncolytic adenoviruses enhance CAR-T cell therapeutic efficacy and reprogram tumor microenvironment in glioblastoma
2022 · Molecular Therapy · 181 citations
https://doi.org/10.1016/j.ymthe.2022.08.021
Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein
2021 · Journal of Nanobiotechnology · 95 citations
https://doi.org/10.1186/s12951-021-00768-w
BCMA/CD47-directed universal CAR-T cells exhibit excellent antitumor activity in multiple myeloma
2024 · Journal of Nanobiotechnology · 14 citations
https://doi.org/10.1186/s12951-024-02512-6
Tumor immunotherapy: past, present, and future
2025 · International Journal of Surgery · 2 citations
https://doi.org/10.1097/js9.0000000000002919
Prognosis and immunological characteristics of HDAC family in pan-cancer through integrative multi-omic analysis
2024 · Egyptian Journal of Medical Human Genetics · 1 citations
https://doi.org/10.1186/s43042-024-00518-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat